Schisandrin B

五味子乙素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSchisandrin B
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitorsP-glycoprotein 1 inhibitors
TargetsSerine-protein kinase ATRP-glycoprotein 1
Therapy Area/IndicationsCardiotoxicity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Dinghui Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Dinghui Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiotoxicity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A